Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 1.13%338.69M | -4.77%747.02M | -11.55%334.92M | -5.50%784.45M | -5.57%378.67M | -6.66%830.12M | -0.32%401M | 2.47%889.37M | 9.36%402.3M | -5.26%867.97M |
| Operating income | 1.13%338.69M | -4.77%747.02M | -11.55%334.92M | -5.50%784.45M | -5.57%378.67M | -6.66%830.12M | -0.32%401M | 2.47%889.37M | 9.36%402.3M | -5.26%867.97M |
| Cost of sales | 1.06%-193.97M | 3.80%-443.16M | 12.27%-196.05M | 4.27%-460.66M | 5.53%-223.46M | 6.41%-481.22M | 1.03%-236.54M | -1.10%-514.21M | -8.26%-239.01M | 4.32%-508.63M |
| Operating expenses | 1.06%-193.97M | 3.80%-443.16M | 12.27%-196.05M | 4.27%-460.66M | 5.53%-223.46M | 6.41%-481.22M | 1.03%-236.54M | -1.10%-514.21M | -8.26%-239.01M | 4.32%-508.63M |
| Gross profit | 4.21%144.72M | -6.15%303.86M | -10.53%138.87M | -7.20%323.78M | -5.63%155.21M | -7.00%348.9M | 0.72%164.46M | 4.40%375.16M | 11.02%163.29M | -6.55%359.34M |
| Selling expenses | -2.67%-55.72M | 1.47%-122.16M | 8.19%-54.27M | 2.22%-123.98M | 4.99%-59.12M | 8.86%-126.79M | 4.43%-62.22M | 2.40%-139.12M | -3.62%-65.11M | 2.14%-142.55M |
| Administrative expenses | 0.38%-34.33M | -1.72%-68.54M | -0.85%-34.46M | 10.40%-67.38M | -5.22%-34.17M | -1.63%-75.21M | 5.96%-32.48M | -9.29%-74M | -4.01%-34.54M | 2.45%-67.71M |
| Impairment and provision | ---- | ---- | ---- | -97.56%6.97M | -95.17%14.47M | --285.97M | --299.48M | ---- | ---- | -15,605.89%-1.02B |
| -Goodwill impairment | ---- | ---- | ---- | 58.55%-7.5M | ---- | ---18.1M | ---- | ---- | ---- | -616.34%-46.33M |
| -Other impairment is provision | ---- | ---- | ---- | -95.24%14.47M | -95.17%14.47M | --304.07M | --299.48M | ---- | ---- | ---969.52M |
| Special items of operating profit | 29.00%-48.94M | 11.18%-131.1M | 11.78%-68.93M | -0.83%-147.6M | 31.75%-78.14M | 26.60%-146.39M | -17.66%-114.5M | 2.67%-199.45M | 15.27%-97.31M | 19.33%-204.91M |
| Operating profit | 130.43%5.72M | -118.56%-17.95M | -973.90%-18.8M | -102.87%-8.21M | -100.69%-1.75M | 865.94%286.48M | 856.62%254.75M | 96.51%-37.4M | 47.24%-33.67M | -1,077.31%-1.07B |
| Financing income | -34.02%1.23M | -23.28%4.04M | -15.43%1.86M | 91.46%5.27M | 77.32%2.2M | -19.78%2.75M | -28.51%1.24M | -40.30%3.43M | -56.85%1.73M | -4.31%5.75M |
| Financing cost | 16.69%-93.43M | -14.10%-222.1M | -38.85%-112.15M | -124.76%-194.66M | -238.97%-80.77M | -47.80%-86.61M | -0.46%-23.83M | 27.68%-58.6M | 55.37%-23.72M | 20.46%-81.03M |
| Earning before tax | 33.01%-86.48M | -19.44%-236.01M | -60.72%-129.1M | -197.52%-197.6M | -134.60%-80.33M | 318.89%202.62M | 517.14%232.16M | 91.93%-92.57M | 50.72%-55.66M | -513.69%-1.15B |
| Tax | 26.76%-4.5M | 19.82%-11.11M | 33.02%-6.15M | 20.47%-13.86M | -11.26%-9.18M | -17.22%-17.43M | -34.72%-8.25M | -32.81%-14.87M | -142.92%-6.12M | -16.29%-11.2M |
| After-tax profit from continuing operations | 32.73%-90.98M | -16.86%-247.12M | -51.10%-135.25M | -214.19%-211.46M | -139.97%-89.51M | 272.37%185.19M | 462.43%223.91M | 90.72%-107.44M | 46.49%-61.78M | -489.32%-1.16B |
| After-tax profit from non-continuing business | 55.09%-3.69M | ---- | ---8.21M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning after tax | 34.01%-94.67M | -16.86%-247.12M | -60.28%-143.46M | -214.19%-211.46M | -139.97%-89.51M | 272.37%185.19M | 462.43%223.91M | 90.72%-107.44M | 46.49%-61.78M | -489.32%-1.16B |
| Minority profit | 105.93%4.03M | -10.55%8.91M | -61.23%1.96M | -76.71%9.96M | -83.48%5.04M | 541.47%42.77M | 60,958.00%30.53M | 107.08%6.67M | 101.39%50K | -12,530.34%-94.22M |
| Shareholders should account for profits from continuing business | 31.02%-95.66M | ---- | ---138.68M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Shareholders should account for profits from non-continuing business | 54.96%-3.04M | ---- | ---6.74M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 32.13%-98.7M | -15.63%-256.03M | -53.80%-145.41M | -255.47%-221.43M | -148.89%-94.55M | 224.81%142.42M | 412.76%193.38M | 89.28%-114.11M | 44.73%-61.83M | -439.30%-1.06B |
| Basic earnings per share | 32.15%-0.0249 | -15.74%-0.0647 | -53.56%-0.0367 | -255.28%-0.0559 | -148.88%-0.0239 | 225.00%0.036 | 213.46%0.0489 | 89.29%-0.0288 | 155.12%0.0156 | -439.76%-0.2688 |
| Diluted earnings per share | 32.15%-0.0249 | -15.74%-0.0647 | -53.56%-0.0367 | -255.28%-0.0559 | -148.88%-0.0239 | 225.00%0.036 | 213.46%0.0489 | 89.29%-0.0288 | 155.12%0.0156 | -439.76%-0.2688 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.